Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Vital KSK Holdings Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Vital KSK Holdings şirketinin toplam hissedar öz sermayesi ¥106.6B ve toplam borcu ¥7.4B olup, bu da borç-öz sermaye oranını 7% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ¥321.9B ve ¥215.4B dir. Vital KSK Holdings 'in FAVÖK'ü ¥5.5B faiz karşılama oranı -8.8 dur. Şirketin ¥32.8B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

7.0%

Borç/özkaynak oranı

JP¥7.44b

Borç

Faiz karşılama oranı	-8.8x
Nakit	JP¥32.77b
Eşitlik	JP¥106.57b
Toplam yükümlülükler	JP¥215.38b
Toplam varlıklar	JP¥321.95b

Son finansal sağlık güncellemeleri

These 4 Measures Indicate That Vital KSK Holdings (TSE:3151) Is Using Debt Safely

Aug 07

Recent updates

These 4 Measures Indicate That Vital KSK Holdings (TSE:3151) Is Using Debt Safely

Aug 07

Impressive Earnings May Not Tell The Whole Story For Vital KSK Holdings (TSE:3151)

May 22

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 3151 'nin kısa vadeli varlıkları ( ¥206.4B ) kısa vadeli yükümlülüklerini ( ¥197.2B ) aşıyor.

Uzun Vadeli Yükümlülükler: 3151 şirketinin kısa vadeli varlıkları ( ¥206.4B ) uzun vadeli yükümlülüklerini ( ¥18.2B ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 3151 şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: 3151 'nin borç/öz sermaye oranı son 5 yılda 17.3% seviyesinden 7% seviyesine düştü.

Borç Kapsamı: 3151 'nin borcu işletme nakit akışı ( 316.9% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: 3151 ödediğinden daha fazla faiz kazandırıyor, dolayısıyla faiz ödemelerinin karşılanması bir sorun teşkil etmiyor.

Vital KSK Holdings Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

These 4 Measures Indicate That Vital KSK Holdings (TSE:3151) Is Using Debt Safely

Recent updates

Upcoming dividend of JP¥21.00 per share

Vital KSK Holdings, Inc. to Report Q2, 2025 Results on Nov 01, 2024

Now 20% overvalued after recent price rise

These 4 Measures Indicate That Vital KSK Holdings (TSE:3151) Is Using Debt Safely

Final dividend of JP¥21.00 announced

Vital KSK Holdings, Inc. to Report Q1, 2025 Results on Aug 05, 2024

Impressive Earnings May Not Tell The Whole Story For Vital KSK Holdings (TSE:3151)

Full year 2024 earnings released: EPS: JP¥115 (vs JP¥92.69 in FY 2023)

Vital KSK Holdings, Inc. Announces Dividend for the Fiscal Year Ended March 31, 2024, Payable on June 5, 2024

Vital KSK Holdings, Inc. (TSE:3151) announces an Equity Buyback for 2,000,000 shares, representing 3.85% for ¥3,000 million.

Upcoming dividend of JP¥22.00 per share

Vital KSK Holdings, Inc. to Report Fiscal Year 2024 Results on May 13, 2024

Third quarter 2024 earnings released: EPS: JP¥53.65 (vs JP¥19.23 in 3Q 2023)

Vital KSK Holdings, Inc. to Report Q3, 2024 Results on Feb 07, 2024

Vital KSK Holdings, Inc. (TSE:3151) announces an Equity Buyback for 700,000 shares, representing 1.38% for ¥840 million.

Second quarter 2024 earnings released: EPS: JP¥28.04 (vs JP¥15.39 in 2Q 2023)

Upcoming dividend of JP¥19.00 per share at 3.9% yield

Vital KSK Holdings, Inc. to Report Q2, 2024 Results on Nov 06, 2023

VITAL KSK HOLDINGS, INC. Provides Year End Dividend Guidance for the Fiscal Year Ending March 31, 2024

First quarter 2024 earnings released: EPS: JP¥17.79 (vs JP¥12.05 in 1Q 2023)

Vital KSK Holdings, Inc. to Report Q1, 2024 Results on Aug 02, 2023

Full year 2023 earnings released: EPS: JP¥92.69 (vs JP¥87.88 in FY 2022)

Vital KSK Holdings, Inc., Annual General Meeting, Jun 28, 2023

Upcoming dividend of JP¥27.00 per share at 4.4% yield

Third quarter 2023 earnings released: EPS: JP¥19.23 (vs JP¥19.25 in 3Q 2022)

Vital KSK Holdings, Inc. to Report Q3, 2023 Results on Feb 03, 2023

Less than half of directors are independent

Second quarter 2023 earnings released: EPS: JP¥15.39 (vs JP¥14.02 in 2Q 2022)

Investor sentiment improved over the past week

Vital KSK Holdings, Inc. to Report Q2, 2023 Results on Nov 07, 2022

Upcoming dividend of JP¥12.00 per share

First quarter 2023 earnings released: EPS: JP¥12.05 (vs JP¥11.66 in 1Q 2022)

Vital KSK Holdings, Inc. to Report Q1, 2023 Results on Aug 02, 2022

Vital KSK Holdings, Inc. (TSE:3151) announces an Equity Buyback for 1,500,000 shares, representing 2.82% for ¥1,029 million.

Full year 2022 earnings released: EPS: JP¥87.88 (vs JP¥21.25 in FY 2021)

Vital KSK Holdings, Inc., Annual General Meeting, Jun 28, 2022

Less than half of directors are independent

Vital KSK Holdings, Inc. to Report Fiscal Year 2022 Results on May 12, 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: EPS JP¥14.02 (vs JP¥12.64 in 2Q 2021)

Upcoming dividend of JP¥12.00 per share

First quarter 2022 earnings released: EPS JP¥11.66 (vs JP¥4.68 loss in 1Q 2021)

Vital KSK Holdings, Inc. (TSE:3151) announces an Equity Buyback for 2,000,000 shares, representing 3.62% for ¥2,000 million.

Full year 2021 earnings released: EPS JP¥21.25 (vs JP¥83.34 in FY 2020)

New 90-day low: JP¥790

Third quarter 2021 earnings released: JP¥1.87 loss per share (vs JP¥39.21 profit in 3Q 2020)

New 90-day low: JP¥798

Vital KSK Holdings, Inc. to Report Q3, 2021 Results on Feb 03, 2021

New 90-day low: JP¥839

New 90-day low: JP¥854

Vital KSK Holdings, Inc. to Report Q2, 2021 Results on Nov 05, 2020

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin